Ivo Kocak

Brno, JM 62500, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)-Exploring Its Possible Clinical Relevance in Cancer Patients.

Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)-Exploring Its Possible Clinical Relevance in Cancer Patients.

Journal: Current oncology (Toronto, Ont.)

Published: May 09, 2022

Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial.

Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial.

Journal: The Lancet. Oncology

Published: April 12, 2022

Oligometastatic Prostate Cancer.

Oligometastatic Prostate Cancer.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: April 19, 2019

Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial.

Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial.

Journal: The Lancet. Oncology

Published: April 06, 2018

Bevacizumab with FOLFIRI or XELIRI in the First-line Therapy of Metastatic Colorectal Carcinoma: Results from Czech Observational Registry.

Bevacizumab with FOLFIRI or XELIRI in the First-line Therapy of Metastatic Colorectal Carcinoma: Results from Czech Observational Registry.

Journal: Anticancer research

Published: May 31, 2015

Long term experience of patients with unresectable or metastatic KIT positive gastrointestinal stromal tumours.

Long term experience of patients with unresectable or metastatic KIT positive gastrointestinal stromal tumours.

Journal: Bratislavske lekarske listy

Published: March 17, 2015

Significant antitumor effectiveness of imatinib in c- kit negative gastrointestinal stromal tumor - case report.

Significant antitumor effectiveness of imatinib in c- kit negative gastrointestinal stromal tumor - case report.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: March 19, 2014

Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial.

Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: June 01, 2013

Epidemiological and clinico-pathological characteristics of patients with renal carcinoma: a single institution analysis of 544 cases

Epidemiological and clinico-pathological characteristics of patients with renal carcinoma: a single institution analysis of 544 cases

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: May 31, 2013

Another approach to targeted therapy of patients with metastatic renal carcinoma with progression in treatment with pazopanib:expert assessment by the Czech Cooperative Group for Metastatic Renal Carcinoma

Another approach to targeted therapy of patients with metastatic renal carcinoma with progression in treatment with pazopanib:expert assessment by the Czech Cooperative Group for Metastatic Renal Carcinoma

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: April 24, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026